Related references
Note: Only part of the references are listed.Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease
H Tanimukai et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Fragmentation of the Golgi apparatus induced by the overexpression of wild-type and mutant human tau forms in neurons
D Liazoghli et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
The role of caspase cleavage of tau in Alzheimer disease neuropathology
CW Cotman et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
Tau pathology in Alzheimer disease and other tauopathies
K Iqbal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1/2, MEK-1/2, and p70 S6, similar to that in Alzheimer's disease
JJ Pei et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Activation of the ERK and JNK signaling pathways caused by neuron-specific inhibition of PP2A in transgenic mice
S Kins et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease
WL An et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Microtubule reduction in Alzheimer's disease and aging is independent of τ filament formation
AD Cash et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bε at Ser539 and the microtubule-associated protein tau at Thr212:: potential role for DYRK as a glycogen synthase kinase 3-priming kinase
YL Woods et al.
BIOCHEMICAL JOURNAL (2001)
Inhibitory role for dual specificity phosphatase VHR in T cell antigen receptor and CD28-induced Erk and Jnk activation
A Alonso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
